SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo; Findings seen among HR-positive, HER2-negative, node-negative early breast cancer patients with recurrence score of 11 to 25.

Press/Media

Period12 Dec 2022

Media coverage

1

Media coverage